HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Denise Jin Selected Research

Therapeutics

3/2013Characterization of the long-term pharmacokinetics of bevacizumab following last dose in patients with resected stage II and III carcinoma of the colon.
4/2012Preclinical pharmacokinetics of MEHD7945A, a novel EGFR/HER3 dual-action antibody, and prediction of its human pharmacokinetics and efficacious clinical dose.
4/2012Preclinical pharmacokinetics of MFGR1877A, a human monoclonal antibody to FGFR3, and prediction of its efficacious clinical dose for the treatment of t(4;14)-positive multiple myeloma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Denise Jin Research Topics

Disease

4Neoplasms (Cancer)
11/2013 - 04/2012
1Rheumatoid Arthritis
01/2018
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2013
1Carcinoma (Carcinomatosis)
03/2013
1Multiple Myeloma
04/2012

Drug/Important Bio-Agent (IBA)

3Monoclonal AntibodiesIBA
01/2018 - 04/2012
1mavrilimumabIBA
01/2018
1onartuzumabIBA
11/2013
1Bevacizumab (Avastin)FDA Link
03/2013
1vesencumabIBA
09/2012
1Neuropilin-1IBA
09/2012
1Immunoglobulin G (IgG)IBA
04/2012
1vofatamabIBA
04/2012
1Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA
04/2012

Therapy/Procedure

3Therapeutics
03/2013 - 04/2012